Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Antiviral Research

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.ANTIVIRAL.2006.01.005PMID 16724398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases

  2005cited by this paper
• Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.

  2005cited by this paper
• High-Throughput Assays Using a Luciferase-Expressing Replicon, Virus-Like Particles, and Full-Length Virus for West Nile Virus Drug Discovery

  2005cited by this paper
• West Nile virus: where are we now?

  2004cited by this paper
• Replication Studies Using Genotype 1a Subgenomic Hepatitis C Virus Replicons

  2003cited by this paper
• The molecular biology of West Nile Virus: a new invader of the western hemisphere.

  2002cited by this paper
• Construction and characterization of subgenomic replicons of New York strain of West Nile virus.

  2002cited by this paper
• Identification of active antiviral compounds against a New York isolate of West Nile virus.

  2002cited by this paper
• Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs

  2001cited by this paper
• Host Factors Involved in West Nile Virus Replication

  2001cited by this paper
• Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut.

  1999cited by this paper
• Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.

  1999cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis.

  1999cited by this paper
• Flavivirus genome organization, expression, and replication.

  1990cited by this paper

• Targeting west nile virus replication by xanthine inhibitors

  2025cites this paper
• Sulfonamides: Antiviral Strategy for Neglected Tropical Disease Virus

  2020cites this paper
• Design, Synthesis, and Evaluation of Dihydrobenzo[cd]indole-6-sulfonamide as TNF-α Inhibitors

  2018cites this paper
• West Nile Virus: An Emerging and Reemerging Infectious Disease

  2018cites this paper
• Computational predictions suggest that structural similarity in viral polymerases may lead to comparable allosteric binding sites.

  2016cites this paper
• An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection

  2016cites this paper
• The Antiviral Properties of Melaleuca alternifolia concentrate (MAC) against West Nile virus

  2015cites this paper
• Generation of West Nile Virus Infectious Clones Containing Amino Acid Insertions Between Capsid and Capsid Anchor

  2014cites this paper
• West Nile Virus: Biology, Transmission, and Human Infection

  2012cites this paper
• High Throughput Screening for Small Molecule Enhancers of the Interferon Signaling Pathway to Drive Next-Generation Antiviral Drug Discovery

  2012cites this paper
• Towards a West Nile Virus Vaccine

  2012cites this paper
• Identification of a small-molecule inhibitor of dengue virus using a replicon system

  2012cites this paper
• Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity.

  2010cites this paper
• Identification of palmatine as an inhibitor of West Nile virus

  2010cites this paper
• HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity

  2010cites this paper
• Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.

  2010cites this paper
• Identification of Inhibitors of Yellow Fever Virus Replication Using a Replicon-Based High-Throughput Assay

  2009cites this paper
• Progress on the development of therapeutics against West Nile virus.

  2009cites this paper
• NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B–NS3 protease

  2009influential citation
• Nouvelles stratégies pour la conception de molécules antivirales

  2009cites this paper
• Defense Against Biological Weapons (Biodefense)

  2009cites this paper
• Novel Therapeutics Against West Nile Virus

  2009cites this paper
• Antiviral Treatment of Flaviviruses

  2009cites this paper
• Identification and characterization of inhibitors of West Nile virus.

  2009cites this paper
• A global perspective on the epidemiology of West Nile virus.

  2008cites this paper
• The flavivirus polymerase as a target for drug discovery.

  2008cites this paper
• High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery

  2008cites this paper
• West Nile virus genome amplification requires the functional activities of the proteasome

  2008influential citation
• Antiviral Profiles of Novel Iminocyclitol Compounds against Bovine Viral Diarrhea Virus, West Nile Virus, Dengue Virus and Hepatitis B Virus

  2007cites this paper
• The Identification of Novel Small Molecule Inhibitors of West Nile Virus Infection 1 2

  2007cites this paper
• Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo.

  2007cites this paper
• Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection

  2007cites this paper